Cardiac Resynchronization Therapy Market Size, Trends, and Growth Analysis 2026-2033 The cardiac resynchronization therapy (CRT) industry has witnessed significant advancements amid rising cardiovascular disease prevalence, driving innovations in device technology and therapeutic approaches. The evolving landscape reflects rapid integration of smarter implantable devices combined with nuanced patient management strategies, aligning with increased clinical adoption globally. Market Size and Overview The cardiac resynchronization therapy (CRT) market is estimated to be valued at USD 7.94 billion in 2025 and is expected to reach USD 12.42 billion by 2032, growing at a compound annual growth rate (CAGR) of 6.6% from 2025 to 2032. https://www.coherentmi.com/industry-reports/cardiac-resynchronization-therapy-market